Abstract: Durability, reliability, and efficiency remain the primary barriers that impede the commercialization of proton exchange membrane (PEM) fuel cells. Prognostics and health management (PHM) is ...
BOSTON--(BUSINESS WIRE)--Boston Cell Standards today announced the publication of the CASI-01 study in Lancet: eBioMedicine demonstrating that calibration dramatically improves the accuracy and ...
Boston Cell Standards today announced the publication of the CASI-01 study in Lancet: eBioMedicinedemonstrating that calibration dramatically improves the accuracy and reproducibility of ...
HER2 IHC testing guides eligibility for targeted therapies such as trastuzumab and trastuzumab deruxtecan (T-DXd). However, the growing importance of identifying HER2-low tumors has revealed critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback